Assessment of 193 candidate genes for retinopathy in African Americans with type 1 diabetes

Archives of Ophthalmology

Volumn 127, Issue 5, 2009, Pages 605-612

  Roy, Monique S ^a   Hallman, D Michael ^b   Fu, Yi Ping ^b   Machado, Mirta ^b   Hanis, Craig L ^b  

^a INSTITUTE OF OPHTHALMOLOGY AND VISUAL SCIENCE   (United States)

^b UNIVERSITY OF TEXAS SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; GLUCOSE TRANSPORTER;

ADULT; AFRICAN AMERICAN; ANGIOGENESIS; ARTICLE; BLOOD ANALYSIS; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CLINICAL EVALUATION; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE COURSE; DISEASE DURATION; DISEASE SEVERITY; EYE EXAMINATION; FEMALE; FOLLOW UP; GENE; GENETIC ASSOCIATION; GENOTYPE; GLUCOSE METABOLISM; HEREDITY; HUMAN; HYPERTENSION; INFLAMMATION; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEUROTRANSMISSION; PREVALENCE; PRIORITY JOURNAL; RETINA DEVELOPMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STEREOSCOPIC VISION; STRUCTURED INTERVIEW; UNITED STATES; URINALYSIS; GENETICS; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; RISK FACTOR; SYNAPTIC TRANSMISSION;

ADULT; AFRICAN AMERICANS; BLOOD PRESSURE DETERMINATION; DIABETES MELLITUS, TYPE 1; DIABETIC RETINOPATHY; DISEASE PROGRESSION; FEMALE; GENES; GENOTYPE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; INFLAMMATION; MALE; NEOVASCULARIZATION, PATHOLOGIC; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SYNAPTIC TRANSMISSION;

EID: 65649101798     PISSN: 00039950     EISSN: 15383601     Source Type: Journal    
DOI: 10.1001/archophthalmol.2009.48     Document Type: Article

References (65)

1. National Society to Prevent Blindness. Vision Problems in the US: Data Analysis, Definitions, Data Sources, Detailed Data Tables, Analysis, Interpretation. New York, NY: National Society to Prevent Blindness; 1980.
2. Ferris FL III, Davis M, Aiello L. Treatment of diabetic retinopathy. N Engl J Med. 1999;341(9):667-678. (Pubitemid 29399047)
3. Klein R, Klein B. Vision disorders in diabetes. In: National Diabetes Data Group, ed. Diabetes in America. 2nd ed. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 1995:293-338. NIH publication 95-1468.
4. Roy MS. Diabetic retinopathy in African-Americans with type 1diabetes: The New Jersey 725, II: risk factors. Arch Ophthalmol. 2000;118(1):105-115. (Pubitemid 30036446)
5. Roy MS, Roy A, Affouf M. Depression is a risk factor for poor glycemic control and retinopathy in African-Americans with type 1 diabetes. Psychosom Med. 2007;69(6):537-542. (Pubitemid 47205737)
6. Leslie RD, Pyke D. Diabetic retinopathy in identical twins. Diabetes. 1982;31(1):19-21. (Pubitemid 12254626)
7. Diabetes Control and Complications Trial Research Group. Clustering of long-term complications in families with diabetes in the Diabetes Control and Complications Trial. Diabetes. 1997;46(11):1829-1839. (Pubitemid 27456418)
8. Rema M, Saravanan G, Deepa R, Mohan V. Familial clustering of diabetic retinopathy in South Indian type 2 diabetic patients. Diabet Med. 2002;19(11):910-916. (Pubitemid 35356916)
9. Hallman DM, Huber JC Jr, Gonzalez V, Klein B, Klein R, Hanis C. Familial aggregation of severity of diabetic retinopathy in Mexican Americans from Starr County, Texas. Diabetes Care. 2005;28(5):1163-1168. (Pubitemid 40616629)
10. Monti MC, Lonsdale J, Montomoli C, Montross R, Schlag E, Greenberg D. Familial risk factors for microvascular complications and differential male-female risk in a large cohort of American families with type 1 diabetes. J Clin Endocrinol Metab. 2007;92(12):4650-4655. (Pubitemid 350223440)
11. Looker HC, Nelson R, Chew E, et al. Genome-wide linkage analyses to identify loci for diabetic retinopathy. Diabetes. 2007;56(4):1160-1166. (Pubitemid 46525074)
12. Varma R. Diabetic retinopathy: challenges and future directions. Am J Ophthalmol. 2006;141(3):539-541. (Pubitemid 43265961)
13. Archer DB. Diabetic retinopathy: some cellular, molecular and therapeutic considerations. Eye. 1999;13(pt 4):497-523.
14. Uhlmann K, Kovacs P, Boettcher Y, Hammes H-P, Paschke R. Genetics of diabetic retinopathy. Exp Clin Endocrinol Diabetes. 2006;114(6):275-294. (Pubitemid 44166174)
15. Cai J, Boulton M. The pathogenesis of diabetic retinopathy: old concepts and new questions. Eye. 2002;16(3):242-260. (Pubitemid 34618821)
16. Warpeha KM, Chakravarthy U. Molecular genetics of microvascular disease in diabetic retinopathy. Eye. 2003;17(3):305-311. (Pubitemid 36603287)
17. Al-Kateb H, Mirea L, Xie X, et al. Multiple variants in vascular endothelial growth factor (VEGFA) are risk factors for time to severe retinopathy in type 1 diabetes: The DCCT/EDIC Genetics study. N Engl J Med. 2005;353:2643-2653. (Pubitemid 47195838)
18. Hallman DM, Boerwinkle E, Gonzalez V, Klein B, Klein R, Hanis C. A genome-wide linkage scan for diabetic retinopathy susceptibility genes in Mexican Americans with type 2 diabetes from Starr County, Texas. Diabetes. 2007;56(4):1167-1173. (Pubitemid 46525075)
19. Churchill AJ, Carter J, Ramsden C, et al. VEGF polymorphisms are associated with severity of diabetic retinopathy. Invest Ophthalmol Vis Sci. 2008;49(8):3611-3616.
20. Roy MS. Diabetic retinopathy in African-Americans with type 1 diabetes: The New Jersey 725, I: methodology, population, frequency of retinopathy and visual impairment. Arch Ophthalmol. 2000;118(1):97-104. (Pubitemid 30036445)
21. Roy MS, Affouf M. Six-year progression of retinopathy and associated risk factors in African American patients with type 1 diabetes mellitus: the New Jersey 725. Arch Ophthalmol. 2006;124(9):1297-1306. (Pubitemid 44379864)
22. The Diabetic Retinopathy Study Research Group. A modification of the Airlie House classification of diabetic retinopathy: Diabetic Retinopathy Study report number 7. Invest Ophthalmol Vis Sci. 1981;21:210-226.
23. Early Treatment of Diabetic Retinopathy Study Research Group. Grading diabetic retinopathy from stereoscopic color fundus photographs: an extension of the modified Airlie House classification. ETDRS report number 10. Ophthalmology. 1991;98(5)(suppl):786-806.
24. Early Treatment of Diabetic Retinopathy Study Research Group (ETDRS). Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Ophthalmology. 1991;98(5)(suppl):823-833.
25. Council on Clinical Classifications. International Classification of Diseases, Ninth Revision, Clinical Modification. Vol 1. Ann Arbor, MI: Edwards Brothers Inc; 1978.
26. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20(7):1183-1197. (Pubitemid 27274286)
27. Winter WE, MacLaren N, Riley W, Clarke D, Kappy M, Spillar R. Maturity-onset diabetes of youth in black Americans. N Engl J Med. 1987;316(6):285-291. (Pubitemid 17036375)
28. de Bakker PIW, Yelensky R, Pe'er I, Gabriel SB, Daly MJ, Altshuler D. Efficiency and power in genetic association studies. Nat Genet. 2005;37(11):1217-1223.
29. Hodgkinson CA, Yuan Q, Xu K, et al. Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol. 2008;43(5):505-515.
30. Zaykin DV, Westfall PH, Young SS, Karnoub MA, Wagner MH, Ehm MG. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered. 2002;53(2):79-91. (Pubitemid 34621657)
31. Mathias RA, Gao P, Goldstein JL, et al. A graphical assessment of p-values from sliding window haplotype tests of association to identify asthma susceptibility loci on chromosome 11q. BMC Genet. 2006;7:38. (Pubitemid 44173140)
32. Diehn JJ, Diehn M, Marmor M, Brown P. Differential gene expression in anatomical compartments of the human eye. Genome Biol. 2005;6(9):R74.
33. Kumagai AK, Glasgow B, Pardridge W. GLUT1 glucose transporter expression in the diabetic and nondiabetic human eye. Invest Ophthalmol Vis Sci. 1994;35(6):2887-2894. (Pubitemid 24149803)
34. Takagi H, King G, Aiello L. Hypoxia upregulates glucose transport activity through adenosine-mediated increase of GLUT1 expression in retinal capillary endothelial cells. Diabetes. 1998;47(9):1480-1488. (Pubitemid 28396953)
35. Sone H, Deo B, Kumagai A. Enhancement of glucose transport by vascular endothelial growth factor in retinal endothelial cells. Invest Ophthalmol Vis Sci. 2000;41(7):1876-1884. (Pubitemid 30354363)
36. Fernandes R, Suzuki K, Kumagai A. Inner blood-retinal barrier GLUT1 in long-term diabetic rats: an immunogold electron microscopic study. Invest Ophthalmol Vis Sci. 2003;44(7):3150-3154. (Pubitemid 36759786)
37. Gardner TW, Antonetti D, Barber A, LaNoue KF, Levison SW. Diabetic retinopathy: more than meets the eye. Surv Ophthalmol. 2002;47(suppl 2):S253-S262. (Pubitemid 36351245)
38. The Diabetes Control and Complications Trial Research Group. The effect of intensive diabetes treatment on the progression of diabetic retinopathy in insulin-dependent diabetes mellitus. Arch Ophthalmol. 1995;113(1):36-51.
39. Tarnow L, Grarup N, Hansen T, Parving H-H, Pedersen O. Diabetic microvascular complications are not associated with two polymorphisms in the GLUT-1 and PC-1 genes regulating glucose metabolism in Caucasian type 1 diabetic patients. Nephrol Dial Transplant. 2001;16(8):1653-1656. (Pubitemid 32750459)
40. Hodgkinson AD, Page T, Millward B, Demaine A. A novel polymorphism in the 5′ flanking region of the glucose transporter (GLUT1) gene is strongly associated with diabetic nephropathy in patients with type 1 diabetes mellitus. J Diabetes Complications. 2005;19(2):65-69. (Pubitemid 40312617)
41. Nayak MS, Kita M, Marmor M. Protection of rabbit retina from ischemic injury by superoxide dismutase and catalase. Invest Ophthalmol Vis Sci. 1993;34(6):2018-2022. (Pubitemid 23148638)
42. Chai D, Wang B, Shen L, Pu J, Zhang X, He B. RXR agonists inhibit high-glucose induced oxidative stress by repressing PKC activity in human endothelial cells. Free Radic Biol Med. 2008;44(7):1334-1347.
43. Flekac M, Skrha J, Hilgertova J, Lacinova Z, Jarolimkova M. Gene polymorphisms of superoxide dismutases and catalase in diabetes mellitus. BMC Med Genet. 2008;9:30.
44. Papapetropoulos A, Garcia-Cardeña G, Dengler T, Maisonpierre PC, Yancopoulos GD, Sessa WC. Direct actions of angiopoietin-1 on human endothelium: evidence for network stabilization, cell survival, and interaction with other angiogenic growth factors. Lab Invest. 1999;79(2):213-223. (Pubitemid 29110651)
45. Wang YL, Hui Y, Guo B, Ma J. Strengthening tight junctions of retinal microvascular endothelial cells by pericytes under normoxia and hypoxia involving angiopoietin-1 signal way. Eye. 2007;21(12):1501-1510.
46. Sturn DH, Feistritzer C, Mosheimer B, et al. Angiopoietin affects neutrophil migration. Microcirculation. 2005;12(5):393-403. (Pubitemid 41122464)
47. Kim I, Ryan A, Rohan R, et al. Constitutive expression of VEGF, VEGFR-1, and VEGFR-2 in normal eyes. Invest Ophthalmol Vis Sci. 1999;40(9):2115-2121. (Pubitemid 29365177)
48. Caldwell RB, Bartoli M, Behzadian A, et al. Vascular endothelial growth factor and diabetic retinopathy: role of oxidative stress. Curr Drug Targets. 2005;6(4):511-524. (Pubitemid 40916276)
49. Usui T, Ishida S, Yamashiro K, et al. VEGF164(165)as the pathological form: differential leukocyte and endothelial responses through VEGFR1 and VEGFR2. Invest Ophthalmol Vis Sci. 2004;45(2):368-374. (Pubitemid 38140491)
50. Joussen AM, Poulaki V, Ly Le M, et al. A central role for inflammation in the pathogenesis of diabetic retinopathy. FASEB J. 2004;18(12):1450-1452. (Pubitemid 39561611)
51. Wong TY, Cruickshanks K, Klein R, et al. HLA-DR3 and DR4 and their relation to the incidence and progression of diabetic retinopathy. Ophthalmology. 2002;109(2):275-281. (Pubitemid 34106030)
52. Bollen M, Gijsbers R, Ceulemans H, Stalmans W, Stefan C. Nucleotide pyrophosphatases/phosphodiesterases on the move. Crit Rev Biochem Mol Biol. 2000;35(6):393-432. (Pubitemid 32095990)
53. DeFronzo RA, Hendler R, Simonson D. Insulin resistance is a prominent feature in insulin-dependent diabetes. Diabetes. 1982;31(9):795-801. (Pubitemid 12062869)
54. Schwartz MA. Integrin signaling revisited. Trends Cell Biol. 2001;11(12):466-470. (Pubitemid 33079137)
55. Roth T, Podesta F, Stepp MA, Boeri D, Lorenzi M. Integrin overexpression induced by high glucose and by human diabetes: potential pathway to cell dysfunction in diabetic microangiopathy. Proc Natl Acad Sci U S A. 1993;90(20):9640-9644. (Pubitemid 23315841)
56. Friedlander M, Theesfeld C, Sugita M, et al. Involvement of integrins alpha v beta 3 and alpha v beta 5 in ocular neovascular diseases. Proc Natl Acad Sci U S A. 1996;93(18):9764-9769.
57. Missale C, Nash R, Robinson SW, Jaber M, Caron MG. Dopamine receptors: from structure to function. Physiol Rev. 1998;78(1):189-225. (Pubitemid 28070979)
58. Huemer K-H, Garhöfer G, Zawinka C, et al. Effects of dopamine on human retinal vessel diameter and its modulation during flicker stimulation. Am J Physiol Heart Circ Physiol. 2003;284(1):H358-H363. (Pubitemid 36076304)
59. Sato M, Soma M, Nakayama T, Kanmatsuse K. Dopamine D1 receptor gene polymorphism is associated with essential hypertension. Hypertension. 2000;36(2):183-186. (Pubitemid 30626986)
60. Beige J, Bellmann A, Sharma A, Gessner R. Ethnic origin determines the impact of genetic variants in dopamine receptor gene (DRD1) concerning essential hypertension. Am J Hypertens. 2004;17(12, pt 1):1184-1187. (Pubitemid 40029418)
61. Yakel J. The 5-HT3 receptor channel: function, activation and regulation. Endo M, Kurachi Y, Mishina M, eds. Pharmacology of Ionic Channel Function-Activators and Inhibitors: Handbook of Experimental Pharmacology. Berlin, Germany: Springer-Verlag. 2000;147:541-560.
62. Raab S, Plate K. Different networks, common growth factors: shared growth factors and receptors of the vascular and the nervous system. Acta Neuropathol. 2007;113(6):607-626. (Pubitemid 46863898)
63. Nishimura DY, Fath M, Mullins R, et al. Bbs-2 null mice have neurosensory deficits, a defect in social dominance, and retinopathy associated with mislocalization of rhodopsin. Proc Natl Acad Sci U S A. 2004;101(47):16588- 16593. (Pubitemid 39557757)
64. Yue Y, Grossmann B, Galetzka D, Zechner U, Haaf T. Isolation and differential expression of two isoforms of the ROBO2/Robo2 axon guidance receptor gene in humans and mice [published online ahead of print July 10, 2006]. Genomics. 2006;88(6):772-778.
65. Carmeliet P, Tessier-Lavigne M. Common mechanisms of nerve and blood vessel wiring. Nature. 2005;436(7048):193-200. (Pubitemid 41021263)